Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a $100 million global licensing and research collaboration. The company will partner with Massachusetts-based Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) on potential cardio-metabolic disease, neurodegeneration and pain treatments. The deal also involves a $100 million equity investment from Lilly. More than 10 targets are expected to be involved.
Lilly says Dicerna could receive some $350 million per treatment that hits certain development and commercialization milestones. A tiered royalty arrangement involving product sales is also included.
Lilly Chief Scientific Officer Daniel Skovronsky says "at Lilly, we go to where breaking science meets unmet medical needs. We are excited to collaborate with Dicerna and utilize their RNAi expertise to study targets that up until now have proven to be very technically challenging. RNAi has the potential to treat an array of diseases that are of strategic importance to Lilly. Together with Dicerna, we aim to employ this emerging modality for greater success in drug development."
Under terms of the agreement, Lilly says Dicerna will work exclusively with it in the neurodegeneration and pain fields and selectively in cardio-metabolic disease fields. The deal still needs regulatory approvals. You can connect to more about the agreement by clicking here.
By Adam Gibson Architectural Designer, Adam Gibson Design for Living
There are currently 78 million baby boomers in the U.S., making up 25% of the population and controlling 67% ($28 trillion) of the country’s wealth, according to the Living In Place Institute. AARP says 90% of people surveyed want to remain as long as possible in their homes. The majority of those 65 and older remodel their home to make it safer and accessible. In fact, 45% of all remodeling work is being done for people over the age of 65. With this amount of data supporting...
Two-EE's Winery in Huntington has announced it will adopt a new age policy begining in August. Our partners at WPTA-TV report the winery will no longer allow people aged under 21 to visit the establishment due to ongoing problems with unsupervised or misbehaving children.
Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) is one step closer to adding to its portfolio. Shareholders of Aratana Therapeutics Inc. (Nasdaq: PETX), voted overwhelmingly in favor of proposed $245 million purchase by Elanco.
A new mixed-use development is coming to Fishers. Thompson Thrift Retail Group has announced the development of The Station, an office building that is part of an overall project that includes a 150-room hotel, a future retail pad along 116th Street and nearly 40 3-story townhomes.
Port of Indiana-Burns Harbor to Host First Commissioning Ceremony in Indiana for a U.S. Navy Vessel Littoral Combat Ship Will Bear USS Indianapolis Name The Port of Indiana-Burns Harbor will host Indiana’s first U.S. Navy vessel commissioning ceremony when it commissions the USS Indianapolis littoral combat ship.
The city of Bloomington is looking to continue the redevelopment of the former Showers Brothers Furniture Co. complex. Following the successful renovation of a former furniture factory into The Mill coworking space and incubator, the city is now planning to sell the Kiln, a one-story facility that was previously used to dry lumber before being used to fabricate furniture. The Kiln is located adjacent to The Mill and Alex Crowley, director of economic and sustainable development for...